- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Larotinib
Total 505 results
-
Bristol-Myers SquibbCompletedBreast CancerUnited States, Peru, Argentina, Mexico
-
Novartis PharmaceuticalsCompletedBreast NeoplasmsUnited States, France, Spain, United Kingdom, Croatia, Turkey, Netherlands, Argentina, Australia, Canada, Czechia, Germany, Italy, Poland, Russian Federation, Brazil, Bulgaria, Chile, Denmark, Hungary, Ireland, Peru, South Africa, Col... and more
-
SCRI Development Innovations, LLCGlaxoSmithKlineTerminatedHER2 Positive Esophagogastric CancerUnited States
-
GlaxoSmithKlineTerminatedNeoplasms, Breast | Relapsed Breast CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); United States Department of DefenseCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
GlaxoSmithKlineWithdrawn
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
Tianjin Medical University Cancer Institute and...Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHER2+ Early or Locally Advanced Breast Cancer
-
Jinming YuJiangsu HengRui Medicine Co., Ltd.UnknownMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
Janssen-Cilag International NVCompletedChronic Hepatitis CAustralia, France, United Kingdom, Spain, Russian Federation, Brazil, Poland, Sweden
-
China Medical University HospitalTerminated
-
Hoffmann-La RocheCompletedHepatitis C, ChronicCanada, United States
-
Tibotec BVBACompleted
-
NYU Langone HealthNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsTerminatedSystemic Lupus ErythematosusUnited States
-
Tianjin Medical University Cancer Institute and...Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
Shengjing HospitalRecruiting
-
Fudan UniversityRecruiting
-
M.D. Anderson Cancer CenterCERN Foundation - Collaborative Ependymoma Research NetworkCompletedBrain Cancer | Pediatric CancersUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Baylor Breast Care CenterGlaxoSmithKline; Translational Breast Cancer Research ConsortiumActive, not recruitingBreast CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Sun Yat-sen UniversityNot yet recruiting
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineActive, not recruitingHead and Neck Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States
-
Ruijin HospitalJiangsu HengRui Medicine Co., Ltd.UnknownBreast Cancer | HER2-positive Breast Cancer | ER-positive Breast Cancer
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownBreast Cancer | HER2 Positive | Combination ChemotherapyChina
-
Yantai Yuhuangding HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Naval Medical Center Camp LejeuneRecruiting
-
Shengjing HospitalRecruiting
-
Fudan UniversityRecruitingHER2-positive Breast Cancer | Estrogen Receptor-positive Breast CancerChina
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastSpain, United States, Argentina, Austria, Italy, Russian Federation, Thailand, Brazil, Peru, Philippines, Hong Kong, Mexico
-
Shanghai Jiao Tong University School of MedicineRenJi Hospital; Huashan Hospital; Ruijin Hospital; Eastern Hepatobiliary Surgery... and other collaboratorsUnknownGallbladder Cancer | Cholangiocarcinoma of the Extrahepatic Bile DuctChina
-
Boehringer IngelheimCompleted
-
German Breast GroupAGO Study GroupCompleted
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Male Breast CarcinomaUnited States
-
Guangdong Provincial People's HospitalNot yet recruitingNeoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
-
Sun Yat-sen UniversityRecruiting
-
Quynh-Thu LeGlaxoSmithKlineTerminatedHead and Neck Cancer | Carcinoma, Squamous Cell | Head and Neck CancersUnited States
-
Hoffmann-La RocheCompleted
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHealthy SubjectsChina
-
National Cancer Institute (NCI)Active, not recruitingCarcinoma, Non-Small-Cell Lung | Carcinoma, Small Cell Lung | Carcinoma, ThymicUnited States
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHealthy SubjectsChina
-
Fudan UniversityUnknown
-
Fudan UniversityRecruitingBreast Cancer | Metastatic CancerChina
-
Peking Union Medical College HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerUnited States, Spain, Israel, Italy, Korea, Republic of, Belgium, Australia, Czechia, Japan, Brazil, France, United Kingdom, Turkey, Greece, Germany
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany